Order Article Reprints

Nguyen QTT, Park HS, Lee TJ, Choi K-M, Park JY, Kim D, Kim JH, Park J, Lee E-J. DKK3, Downregulated in Invasive Epithelial Ovarian Cancer, Is Associated with Chemoresistance and Enhanced Paclitaxel Susceptibility via Inhibition of the β-Catenin-P-Glycoprotein Signaling Pathway. Cancers. 2022; 14(4):924. https://doi.org/10.3390/cancers14040924

Nguyen, Que Thanh Thanh, Hwang Shin Park, Tae Jin Lee, Kyung-Mi Choi, Joong Yull Park, Daehan Kim, Jae Hyung Kim, Junsoo Park, and Eun-Ju Lee. 2022. "DKK3, Downregulated in Invasive Epithelial Ovarian Cancer, Is Associated with Chemoresistance and Enhanced Paclitaxel Susceptibility via Inhibition of the β-Catenin-P-Glycoprotein Signaling Pathway" Cancers 14, no. 4: 924. https://doi.org/10.3390/cancers14040924

Nguyen, Q. T. T., Park, H. S., Lee, T. J., Choi, K.-M., Park, J. Y., Kim, D., Kim, J. H., Park, J., & Lee, E.-J. (2022). DKK3, Downregulated in Invasive Epithelial Ovarian Cancer, Is Associated with Chemoresistance and Enhanced Paclitaxel Susceptibility via Inhibition of the β-Catenin-P-Glycoprotein Signaling Pathway. Cancers, 14(4), 924. https://doi.org/10.3390/cancers14040924